Why CureVac (CVAC) Shares Are Volatile
CureVac shares have been volatile over the past week, gaining some 25%. The stock has seen increased trading volume following ...
bovnews5d
Why Did Leerink Partners Give CureVac BV (CVAC) Stock Market Perform Rating?
Leerink Partners has recently reduced CureVac BV (CVAC) stock to Market Perform rating, as announced on April 25, 2024, according to Finviz. Earlier, on June 8, 2023, SVB Securities had initiated the ...
Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus
Moderna stock ( MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week ...
CureVac: Latest GBM Data Bodes Well For Next Program Check Point
CureVac recently released new clinical data. Why should investors care? Click here to find out why I am bullish on CVAC stock ...
Why CureVac (CVAC) Stock Is Moving
Shares of CureVac fell by 12.3% Wednesday afternoon. The pullback may stem from profit-taking after Tuesday's strong gains ...
jurnaltime6d
US Bird Flu Death Sends Moderna Stock Soaring 10% This Week!
Financial analysts on Wall Street, as monitored by Bloomberg, are anticipating that the company will unveil a loss of slightly over $9 per share for the fiscal year 2024, with sales expected to ...